Company page

Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. (ticker: KLRA) is a public company based in the United States with a market capitalization of approximately $2.4 billion. The company focuses on developing innovative therapies to address unmet medical needs. Kailera is committed to advancing its research and development efforts to improve patient outcomes.